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INTRODUCTION
Levocetirizine dihydrochloride (LCT), (2[4
[(R)(4chlorophenyl) phenylmethyl]1piperazi
nyl]ethoxy]acetic acid dihydrochloride) (Fig. 1) is a
third generation non sedative antihistamine[1], and is
the active enantiomer of cetirizine dihydrochloride.
LCT has the advantages of higher efficacy, less side
effects, and longer duration over other antihistamines,
and has begun to replace cetirizine in clinical therapy
stepwise. It has been chemically proved that half dos
age form of LCTZ (2.5 mg) has comparable antihista
minic activity to normal amount (5.0 mg) of cetiriz
ine in the treatment of allergic rhinitis and chronic idio
pathic urticaria [2]. In many cases, the two racemic
enantiomers differ in their pharmacokinetic and phar
macodynamic properties. Replacing existing recemates
with single isomers has resulted in improved safety
and/or efficacy profile of various recemates [3, 4].
LCT is official in Indian Pharmacopoeia [5]. Liter
ature survey revealed that LCT has been determined in
human serum by reversephase high performance liq
uid chromatography (RPHPLC) along with other
H1receptor antagonists [6] and in plasma by liquid
chromatographytandem mass spectrometry [7].
Xiangping et al. have recently reported a study on the
interaction of LCT with human serum albumin by
molecular spectroscopy [8].
LCT in combination with a number of other drugs
in tablet dosage form has been assayed by UV spec
trophotometry [9, 10], ratio derivative spectropho
tometry [11], TLCdensitometry [12], RPHPLC
[13–16]. However, there are only three reports dealing
with the determination of LCT when present alone in
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its dosage forms. Li Jing et al. have reported an UV
spectrophotometric method [17] to determine effec
tive content of LCT in its tablets. The drug and related
substance in solid oral formulation were assayed by
HPLC [18]. The same technique has been applied for
the stabilityindicating method for the drug in bulk
form and in dosage forms [19] and for the determina
tion of LCT configuration stability in tablets using the
chiral mode [20].
However, many of the reported methods for LCT in
singledosage form, particularly, the chromatographic
methods [18–20] are complex, requiring expensive
instrumental set up and skilled operator which are not
always found in laboratories of developing and under
developed countries. Thus, the need for a simple,
selective and lowcost method is obvious, especially
for routine quality control analysis of pharmaceuticals
containing LCT.
There is only one report, an official method [5], on
the use of titrimetric method for the determination of
LCT. The method consists of the titration with 0.1 M
NaOH in acetone:water medium to the potentiomet
ric end point, but requires large amounts of acetone
and large quantities of LCT. To the best of our knowl
edge, no visible spectrophotometric method is avail
able for the quantification of LCT in pharmaceuticals.
The present manuscript describes two fairly sensitive
titrimetric and two sensitive spectrophotometric
methods for the determination of LCT in both pure
form and in tablet form. The methods make use of the
acidity of levocetirizine dihydrochloride, iodide
present is oxidized by iodate, in amounts equivalent to
the acid present, to iodine which is titrated with thio
sulphate to the starch end point in method A or to the
potentiometric end point in method B. The absor
bance of the liberated iodine is measured at 355 nm in
method C and starchiodine complex at 570 nm in
method D. This reaction has earlier been exploited for
the assay of a number of organic acids [21–24]. The
developed methods are simpler and cost effective, than
many existing methods besides being applicable to
smaller amounts compared to the lone titrimetric
method available [5].
EXPERIMENTAL
Apparatus. A Systronics model 106 digital spectro
photometer provided with 1cm matched quartz cells
was used for absorbance measurements.
Reagents and standards. All chemicals were of ana
lytical reagent grade and distilled water was used to
prepare solutions.
Potassium iodate. A high purity grade of the chem
ical (Merck, Mumbai, India) was used. A saturated
solution of potassium iodate was prepared by stirring
approximately 20 g of the chemical in a beaker con
taining 100 mL water with the help of magnetic stirrer
for 60 minutes. The solution was decanted and filtered
using quantitative filter paper.
Potassium iodide. A saturated solution of potassium
iodide (Merck, Mumbai, India) was prepared just
before use in order to prevent atmospheric oxidation
to iodine.
Sodium thiosulphate. A 0.01 N sodium thiosul
phate was prepared in water and standardized against
0.01 N potassium dichromate.
Saturated Borax. Approximately 30 g of borax
(S.D. Fine Chem., Mumbai, India) was dissolved in
100 mL water and stirred with the help of magnetic
stirrer for 15 min. The solution was decanted and fil
tered. The pH of the solution was between 8 and 9.
1% starch. A paste of 1 g of the chemical (potato
starch, loba chemie, Mumbai, India) in cold water was
dissolved in 100 mL of boiling water. Cooled before
use and prepared afresh every day.
Standard Drug Solution
Pharmaceutical grade levocetirizine dihydrochlo
ride (LCT) was received from Jubilant Life Sciences
Ltd., Mysore, India, as a gift and used as received.
Allercet5 (from Microlabs Ltd. India), Xyzal5 (from
UCB India Pvt Ltd, India) and Lezyncet syrup
(Mepro pharmaceuticals Pvt. Ltd.) were purchased from
commercial sources in the local market. A stock standard
solution equivalent to 2 mg mL–1 for method A and
method B was prepared by dissolving 200 mg of pure drug
in water and diluting to 100 mL in calibrated flask with
water. The stock solution was diluted appropriately to get
working concentration of 100 and 25 mg mL–1 with water
for method C and method D, respectively.
Procedures
Method A. A 10 mL aliquot of pure LCT solution
containing 2–20 mg of LCT was taken in an Erlenm
eyer flask. Five mL each of saturated solution of KIO3
and of KI were added and the flask was stopperred and
let stand for 5 min with occasional swirling. Finally,
1 mL of 1% starch indicator was added and liberated
iodine was titrated against standardized solution of
0.01 N Na2S2O3 until the decoloration of blue color.
The amount of LCT was computed from the fol
lowing formula:
Amount, mg = 
where V = mL of iodine reacted; Mr = relative molec
ular mass of drug; S = strength of titrant, moles/L; n =
number of moles of titrant reacting with per mole of
LCT.
Method B. An aliquot of the standard drug solution
equivalent to 2.0–20.0 mg of LCT was measured
accurately and transferred into a clean 100 mL beaker.
Five ml each of saturated solution of KI and KIO3 was
added. The content was stirred magnetically and the
V Mr S××
n
 ,
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titrant (0.01 N Na2S2O3) was added from a microbu
rette. Near the equivalence point, titrant was added in
0.1 mL increments. After each addition of titrant, the
solution was stirred magnetically for 30 s and the
steady emf was noted. The addition of titrant was con
tinued until there was no significant change in emf on
further addition of titrant. The equivalence point was
determined by applying the graphical method. The
amount of the drug in the measured aliquot was calcu
lated as described under visual titration.
Method C. A 0.5–4.0 mL of 100 μg mL–1 LCT was
added in to a series of 10 mL calibrated flasks by means
of microburette. To each flask, 1 mL each of saturated
KIO3 and KI were added flasks stoppered, content
mixed and let stand for 15 min. Then 2 mL of saturated
borax was added solution and made up to the mark
with water. Absorbance of each solution was measured
at 350 nm against reagent blank.
Method D. Different volumes (0.5–5.0 mL) of
25 μg mL–1 LCT were taken in a series of 10 mL cali
brated flasks. One ml each of saturated KIO3 and KI
solutions were added, flasks were stoppered and con
tent mixed. The flasks were let stand for 15 min before
adding 2 mL of saturated borax and 1 mL of 1% starch
to each flask, and made up to 10 mL with water. Absor
bance of each solution was measured at 570 nm against
reagent blank.
Standard graph was prepared by plotting the absor
bance versus drug concentration, and the concentra
tion of the unknown was read from the calibration
graph or computed from the respective regression
equation.
Procedure for Tablets
Twenty tablets were weighed accurately and ground
into a fine powder. An accurately weighed amount of
the powdered tablet equivalent to 200 mg of LCT was
transferred into a 100 mL calibrated flask. Sixty mL
water was added and the content was shaken thor
oughly for 15–20 min to extract the drug into the liq
uid phase; the volume was finally diluted to the mark
with the water, mixed well and filtered using a What
man No. 42 filter paper. An aliquot of the filtrate
(2 mg mL–1 in LCT) was used for method A and
method B, and diluted to required concentrations and
used for the assay in method C and method D as
described above.
Procedure for the Analysis of Placebo Blank
and Synthetic Mixture
A placebo blank containing starch (35 mg), acacia
(45 mg), sodium citrate (45 mg), hydroxyl cellulose
(40 mg), magnesium stearate (50 mg), talc (40 mg)
and sodium alginate (35 mg) was prepared by mixing
all the components into a homogeneous mixture. A
100 mg of the placebo blank was accurately weighed
and its solution was prepared as described under ‘tab
lets,’ and then subjected to analysis by following the
general procedures.
To the placebo blank of the composition described
above, 100 mg of LCT was added and homogenized,
transferred to a 50 mL calibrated flask and the solution
was prepared as described under “Procedure for tab
lets”, and then subjected to analysis by the procedure
described above. This analysis was performed to study
the interference by excipients normally present in tab
let preparation.
RESULTS AND DISCUSSION
Preliminary experiments showed that LCT is suffi
ciently acidic to release iodine from iodateiodide
mixture allowing the titrimetric and spectrophotomet
ric determination of drug. In titrimetry, the liberated
iodine was titrated with thiosulphate and the end point
being located visually to the starch end point in
method A, and potentiometric end point in method
B, while in spectrophotometry, it was determined by
two different color reactions.
Method Development
Method A and Method B. The quantitative nature
of the reaction between LCT and iodateiodide
reagent was checked by treating 2.0–20.0 mg of drug
with an excess of reagent and determining the iodine
released. For the range studied (2.0–20.0 mg), 5.0 mL
each of saturated solution of iodate and iodide and
reaction time of 5 min was found adequate. The end
point is being located visually to the starch end point
in method A and end point is located potentiometri
cally in method B. The reaction stoichiometry is 1 : 1
(drug : liberated iodine), the COOH group in the drug
moiety is not acidic enough to liberate iodine and
presence of electron releasing group in the side chain
attached to piperazine suppresses the acidic property
of COOH group and hence the liberated iodine is due
the presence of two HCl.
 + 5I– + 6H+ → 3I2 + 3H2O,
I2 + 2Na2S2O3 → 2NaI + Na2S4O6.
Method C and Method D. Absorbance of the liber
ated iodine or starchiodine complex was measured at
350 or 570 nm as deduced from the absorption spectra
of the colored species (Fig. 2). In both the methods,
the reaction was relatively fast in the beginning and
iodine continued to be liberated even after 15 min.
Since most of the iodine was liberated within 15 min,
the reaction was stopped by adding borax to the reac
tion mixture after a standing time of 15 min. The
absorbance remained constant for 45 and 30 min in
method C and method D, respectively. Attempts to
hasten the reaction by heating were unsuccessful
IO3
–
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owing to the volatility of iodine and dissociation of
iodinestarch complex at elevated temperature.
The possible reaction schemes responsible for
change in absorbance as a function of LCT concentra
tion are represented below:
 + 5I– + 6H+ (LCT) → 3I2 + 3H2O 
(Method C: measured at 350 nm),
I2 + Starch → I2—Starch complex 
(Method D: measured at 570 nm).
IO3
–
METHOD VALIDATION
Linearity, Detection and Quantification Limits
Under the optimum conditions a linear relation
was obtained between absorbance and concentration
of LCT in the ranges given in Table 1. The calibration
graph in each instance is described by the equation:
Y = a + bX,
(Where Y = absorbance, a = intercept, b = slope and
X = concentration in μg mL–1). The correlation coef
ficient, intercept and slope for the calibration data are
summarized in Table 1. Sensitivity parameters such as
apparent molar absorptivity and sandell sensitivity val
ues, the limits of detection (LOD) and quantification
(LOQ) are calculated as per the current ICH guide
lines [26] and compiled in Table 1. LOD and LOQ
were calculated according to the same guidelines using
the following formulae:
LOD = 
where σ is the standard deviation of six reagent blank
determinations and S is the slope of the calibration
curve.
Selectivity. The results obtained from placebo
blank and synthetic mixture analyses revealed that the
inactive ingredients used in the tablet preparation did
not interfere in the assay of active ingredient. The
absorbance values obtained from the placebo blank
solution were almost equal to the absorbance of the
blank which revealed no interference from the adju
vants. To study the role of additives added to the syn
3.3 σ×
S
   &  LOQ 10 σ×
S
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Fig. 2. Absorption spectra.
Table 1. Sensitivity and regression parameters
Parameter Method C Method D
λmax, nm 350 570 
Color stability, min 45 30 
Linear range, μg mL–1 5–40  1.25–12.5  
Molar absorptivity(ε), L mol–1 cm–1 1.0 × 104 2.9 × 104 
Sandell sensitivity*, μg cm–2 0.0435 0.0156 
Limit of detection (LOD), μg mL–1 0.34 0.17 
Limit of quantifcation (LOQ), μg mL–1 1.05 0.51
Regression equation, Y**
Intercept (a) 0.00243 0.0192 
Slope (b) 0.0228 0.0677 
Regression coeffcient (r) 0.9982 0.9970 
Standard deviation of intercept (Sa) 0.0223 0.0862 
Standard deviation of slope (Sb) 0.0007 0.0128
Notes: * Limit of determination as the weight in µg per mL of solution, which corresponds to an absorbance of A = 0.001 measured in
a cuvette of crosssectional area 1 cm2  and   = 1 cm; 
** Y = a + bX, Where Y is the absorbance, X is concentration in µg/mL, a is intercept, b is slope, /  = confidence limit
for intercept, /  = confidence limit for slope.
1
tSa± n
tSb± n
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thetic sample, the analysis of synthetic mixture solu
tion prepared as described earlier yielded percent
recoveries of 98.3 ± 2.13, 99.1 ± 1.76, 97.86 ± 1.94 and
101.34 ± 1.91 (n = 5) for method A, method B,
method C and method D, respectively, demonstrated
the accuracy as well as the precision of the proposed
method and complement the findings of the placebo
blank analysis with respect to selectivity.
Precision. The precision of the method was calcu
lated in terms of intermediate precision (intraday and
interday) [26]. Three different concentration of LCT
were analysed in seven replicates during the same day
(intraday precision) and five consecutive days (inter
day precision). The RSD (%) values of intraday and
interday studies showed that the precision was good
(Table 2).
Accuracy. The accuracy of an analytical method
expresses the closeness between the reference value
and the found value. Accuracy was evaluated as per
centage relative error between the measured concen
trations and taken concentrations for LCT (Bias %).
The results obtained are compiled in Table 2 and show
that the accuracy is good for the method.
Application to tablets analysis. The proposed meth
ods were applied to determine LCT in two brands of
tablets The results were statically compared with those
obtained by the official Indian Pharmacopoeial
method [5] for accuracy and precision by applying the
Student’s ttest and variance ratio Ftest. The official
method consisted of acidbase titration to the potenti
ometric end point in acetone: water system. Statistical
analysis of the results using Student’s ttest for accu
racy and Ftest for precision revealed no significant
Table 2.  Evaluation of intraday and interday accuracy and precision
Method LCT taken*
Intraday accuracy and precision Interday accuracy and precision
LCT found** RE, % RSD, % LCT found** RE, % RSD, %
A 6.0
12.0
18.0
5.83
11.80
17.77
1.25
2.29
1.25
1.96
1.22
0.43
5.75
11.71
17.69
2.15
1.78
2.06
2.85
3.46
3.58
B 6.0
12.0
18.0
5.89
11.84
17.84
1.76
1.25
1.15
1.73
1.02
0.90
5.81
11.69
17.75
2.58
3.04
2.36
3.26
2.48
2.46
C 10.0
20.0
30.0
9.83
19.71
29.43
1.69
1.44
1.88
1.73
0.95
1.54
9.78
19.65
29.14
2.46
1.74
2.85
2.76
3.54
3.26
D 5.0
7.5
10.0
4.91
7.38
9.77
1.70
1.47
2.23
0.70
1.91
1.94
4.88
7.35
9.76
2.64
1.92
2.37
3.15
2.64
3.07
* The amount of LCT is in mg for method A and method B; and µg mL–1 for method C and method D; 
** Mean value of three determinations.
Table 3. Results of analysis of tablets by the proposed methods and statistical comparison of the results with the reference
method
Tablets 
analysed**
Label claim, 
mg/tablet
Found* (Percent label claim ±SD)
Reference 
method Method A Method B Method C Method D
aAllercet 5.0 96.48 ± 1.12 97.13 ± 1.14 
t = 1.39 
F = 2.14
98.56 ± 1.42
t = 2.13 
F = 1.60
98.84 ± 1.74 
t = 1.68 
F = 2.41
97.26 ± 1.85 
t = 1.86 
F = 2.72
bXyzal 5.0 98.56 ± 1.36 97.47 ± 0.96 
t = 2.71 
F = 2.00
98.04 ± 1.26 
t = 2.44 
F = 1.16
99.38 ± 1.84 
t = 2.11 
F = 1.87
97.68 ± 1.95 
t = 2.70 
F = 1.47
Notes: * Mean value of 5 determinations. Tabulated tvalue at the 95 % confidence level and for four degrees of freedom is 2.77. Tabu
lated Fvalue at the 95 % confidence level and for four degrees of freedom is 6.39; 
** Marketed by: aMicro labs Ltd, bUCB India Pvt. Ltd.
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difference between the proposed methods and the lit
erature method at the 95% confidence level with
respect to accuracy and precision (Table 3).
The accuracy and validity of the proposed method
were further ascertained by performing recovery stud
ies. Preanalysed tablet powder was spiked with pure
LCT at three concentration levels (50, 100 and 150%
of that in tablet powder) and the total was found by the
proposed methods. In all cases, the added LCT recov
ery percentage values ranged between 96.67 and
103.24. The results of this study given in Table 4 indi
cated that the recovery was good, and that the co for
mulated substances did not interfere in the determina
tion.
CONCLUSIONS
Four methods have been developed for determina
tion of levocetirizine dihydrochloride in bulk drug and
in its dosage forms and validated as per the current
ICH guidelines. The methods use cheap and readily
available chemicals, compared to the lone titrimetric
method [official method], the presented methods are
rather simple and sensitive. The reported methods suf
fer from such draw backs as high cost, and also several
cleanup steps (HPLC). They are time consuming and
often poorly reproducible, some require toxic organic
solvents. Any method chosen for routine analysis
should be reasonably simple, used materials should be
readily available in the laboratory or readily obtain
able, and require a minimum amount of equipment.
The methods are selective as none of the common tab
let excipients contain acidic groups to interfere with
the present proposed methods. The proposed spectro
photometric methods are free from rigid experimental
variables such as pH control, heating or extraction step
and/or use of organic solvents. They are characterized
by high selectivity and comparable sensitivity with
respect to the existing methods. The accuracy, repro
ducibility, simplicity and costeffectiveness of the
methods suggest their application in the quality con
trol laboratories where the modern and expensive
instruments are not available.
Authors thank Jubiliant Life Sciences Limited.
Mysore, India. for gifting pure levocetirizine. Authors
Table 4. Accuracy assessment by recovery experiments
Tablet studied Method LCT in tablet powder taken* Pure LCT added* Total found*
Pure LCT recovered 
(Percent ± SD**)
5.83 3.00 8.73 96.67 ± 1.36
A 5.83 6.00 11.66 97.23 ± 1.28
5.83 9.00 14.72 98.15 ± 1.46
5.91 3.00 8.87 98.90 ± 0.94
B 5.91 6.00 11.85 99.08 ± 0.82
5.91 9.00 14.82 98.64 ± 1.24
Allercet (5 mg)
14.86 10.0 24.72 98.68 ± 1.07
C 14.86 15.0 29.72 99.08 ± 2.12
14.86 20.0 35.12 101.30 ± 1.26
3.89 2.00 5.91 100.53 ± 0.78
D 3.89 4.00 7.99 102.78 ± 0.32
3.89 6.00 10.01 103.24 ± 1.28
Notes: * The amount of LCT is in mg for method A and method B; and µg mL–1 for method C and method D; 
** Mean value of three determinations.
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Fig. 3. Potentiometric titration curve for 10 mg LCT vs.
0.01 N Na2S2O3.
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